Dextran, MW ca 150,000
Dextran, MW ca 150,000
Dextran, MW ca 150,000
Thermo Scientific Chemicals

Dextran, MW ca 150,000

Dextran, CAS # 9004-54-0, is a glucose polymer. It is mainly used to increase electronegativity and reduce erythrocyte aggregation and platelet adhesiveness (anticoagulant activity). | CAS: 9004-54-0 | (C6H9O5)n(C6H10O5)m | 504.44 g/mol
数量:
10 g
50 g
100 g
500 g
1 kg
製品番号(カタログ番号) J63789.A1
または、製品番号J63789-A1
価格(JPY)
-
数量:
1 kg
一括またはカスタム形式をリクエストする
化学物質識別子
CAS9004-54-0
IUPAC NameDextran
Molecular Formula(C6H9O5)n(C6H10O5)m
SMILESO[C@@H]1[C@@H](O)[C@@H](-*)O[C@H](CO[C@H]2O[C@H](CO-*)[C@@H](O)[C@H](O-*)[C@H]2O)[C@H]1O
MDL NumberMFCD00130935
Appearance (Color)White to pale cream
Ash≤2.0%
pH4.5-7.0 (6% solution in water)
FormPowder
Loss on Drying≤7.0%
さらに表示
Dextran is used in a bead form to aid in bioreactor applications, some size-exclusion chromatography matrices and in osmotic stress technique study involved in biological molecules. It can be used as a stabilizing coating to protect metal nanoparticles from oxidation.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

General Description

• Dextran is a glucose polymer biosynthesized by the non-pathogenic Leuconostoc mesenteroides

Application

• Dextran is a complex branched glucan that can be used to enhance electronegativity and reduce erythrocyte aggregation and platelet adhesiveness (anticoagulant activity)
• This compound promotes the activation of plasminogen by inhibiting α-2 antiplasmin
• Dextran can be used to reduce thrombosis in animal models
• It is used in osmotic stress techniques where osmotic pressure is applied to biological molecules
• Dextran can be used as an immobilization agent in biosensors

RUO – Research Use Only

General References:

  1. Zhang, Z.; Amorosa, L. F.; Coyle, S. M.; Macor, M. A.; Lubitz, S. E.; Carson, J. L.; Birnbaum, M. J.; Lee, L. Y.; Haimovich, B. Proteolytic Cleavage of AMPK alpha and Intracellular MMP9 Expression Are Both Required for TLR4-Mediated mTORC1 Activation and HIF-1alpha Expression in Leukocytes. J. Immunol. 2015, 195 (5), 2452-2460.
  2. Kim, N. H.; Pham, N. B.; Quinn, R. J.; Shim, J. S.; Cho, H.; Cho, S. M.; Park, S. W.; Kim, J. H.; Seok, S. H.; Oh, J. W.; Kwon, H. J. The Small Molecule R-(-)-beta-O-Methylsynephrine Binds to Nucleoporin 153 kDa and Inhibits Angiogenesis. Int J Biol Sci. 2015, 11 (9), 1088-1099.